Chairpersons: P. Dugel USA, M. Zarbin USA
Pearse Keane UK
AI for screening vision threatening retinal disease: DR, nAMD
Treatments for GA (update on current clinical trials)
Pravin Dugel USA
New treatments for nAMD
Frank Holz GERMANY
Brolucizumab: where does it fit in?
Marco Zarbin USA
Treatment of diabetic retinopathy with anti-VEGF therapy: When should we intervene?
Update on gene therapy
Update on cell-based therapy for GA and nAMD
Intraoperative OCT: when to use it?
S. Rizzo ITALY
Applications of human amniotic membrane grafts for macular disease